Dr Paul A Gibilisco, MD | |
72 Shepard Rd, Norfolk, CT 06058-1125 | |
(860) 542-5643 | |
Not Available |
Full Name | Dr Paul A Gibilisco |
---|---|
Gender | Male |
Speciality | Internal Medicine - Rheumatology |
Location | 72 Shepard Rd, Norfolk, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013040401 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 023213 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Paul A Gibilisco, MD 72 Shepard Rd, Norfolk, CT 06058-1125 Ph: (860) 542-5643 | Dr Paul A Gibilisco, MD 72 Shepard Rd, Norfolk, CT 06058-1125 Ph: (860) 542-5643 |
News Archive
Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.) is circulating an outline of health care overhaul legislation that includes a requirement that all individuals obtain coverage and requires contributions from employers, the Washington Post reports.
People troubled by depression usually experience their dark moods in an on-again, off-again fashion.
Progressive Medical and PMSI announced today that the two companies have entered into a definitive agreement to merge. The transaction is expected to close in the fourth quarter subject to receipt of regulatory clearance. The combined company, which will be led by Executive Chairman Eileen Auen from PMSI and Co-CEOs Emry Sisson and Tommy Young from Progressive Medical, will deliver comprehensive workers' compensation pharmacy benefit management services including end-to-end pharmacy, ancillary and settlement solutions.
Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced new clinical data presented in an oral presentation for ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use at the 17th Congress of the European Hematology Association (EHA).
› Verified 5 days ago